淘汰的产品包括减少两种早期药物的开发,即用于淋巴畸形的 AVTX-006和用于多发性骨髓瘤患者的 AVTX-007。 该公司将寻求 AVTX-006 的战略替代方案。...查看全文
蹊之美股生物医药2021-07-27 21:11
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
标的公司:Cerecor Inc.(NASDAQ: CERC)
Cerecor Inc.(CERC) 宣布Ib期first-in-class全人源anti-LIGHT(TNFSF14)单克隆抗体CERC-002概念验证研究的初步积极结果,针对中重度克罗恩病(CD)成人患者。
Ib期,开放标签...查看全文
产业链观察2021-05-11 19:40
药闻| 2021年5月11日 - $Cerecor(CERC)$ 是专注于成为罕见病和孤儿疾病治疗开发和商业化的生物制药公司和领导者,今天宣布FDA已将其开发的CERC-002授予“快速通道”称号,以用于治疗住院的新冠肺炎患者。CERC-002是针对LIGHT(肿瘤坏死因子超家族成员14,TNFSF14)的一流的全人类单克隆抗体。#新冠...查看全文
$CERECOR INC(CERC)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2016-05-20 AccNo: 0001558370-16-006101 Size: 207 KB 网页链接
$CERECOR INC(CERC)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2016-05-20 AccNo: 0001558370-16-006099 Size: 752 KB 网页链接
$CERECOR INC(CERC)$ 8-K - Current report Filed: 2016-05-20 AccNo: 0001558370-16-006092 Size: 561 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission...
$CERECOR INC(CERC)$ 8-K - Current report Filed: 2016-05-16 AccNo: 0001558370-16-006013 Size: 142 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$CERECOR INC(CERC)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-05-16 AccNo: 0001558370-16-006015 Size: 4 MB 网页链接
$CERECOR INC(CERC)$ 8-K - Current report Filed: 2016-04-11 AccNo: 0001558370-16-004574 Size: 99 KBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$CERECOR INC(CERC)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2016-04-11 AccNo: 0001558370-16-004576 Size: 126 KB 网页链接
$CERECOR INC(CERC)$ DEF 14A - Other definitive proxy statements Filed: 2016-04-08 AccNo: 0001047469-16-012046 Size: 981 KB 网页链接
$CERECOR INC(CERC)$ 美东时间 2016-06-14 04:00 Cer ad Cacak Annual Shareholders Meeting (Estimated) 网页链接
$CERECOR INC(CERC)$ 8-K - Current report Filed: 2016-03-23 AccNo: 0001104659-16-107029 Size: 124 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接